On May 16, 2024, the Board of Directors of Xenetic Biosciences, Inc. appointed James F. Parslow, the company?s Chief Financial Officer, to the position of Interim Chief Executive Officer. Mr. Parslow will continue to serve as the Company?s principal financial officer. Mr. Parslow, 59, has served as the company?s Chief Financial Officer since April 2017.

Mr. Parslow previously served as Chief Financial Officer, Treasurer and Secretary of World Energy Solutions, Inc. from 2006 until its acquisition in 2015. Mr. Parslow is a Certified Public Accountant with over 35 years of experience serving private and public companies in the biotech, e-commerce, and clean tech industries. He holds an A.B. in Economics and Accounting from the College of the Holy Cross and an M.B.A. with a concentration in Finance from Bentley University.

On May 16, 2024, the Company and Jeffrey F. Eisenberg mutually agreed that Mr. Eisenberg would step down as the Chief Executive Officer of the Company, effective immediately,, and in connection therewith, Mr. Eisenberg resigned as a director of the Company and all of its subsidiaries, as applicable.